Vera Ignjatović: Why Is Thrombosis Research So Far Behind When It Comes to AI and Multi-Omics?
Vera Ignjatović, Founder and Managing Director at Ignis Innovations Pty Ltd, Principal Consultant of Translational Research at Johns Hopkins All Children’s Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in RPTH Journal, adding:
”I am excited to share a paper co-authored with my colleagues Steven Bruzek, MS, MB(ASCP), Grant Vestal, and Neil Goldenberg, MD PhD just published in RPTH Journal that asks a question our field (thrombosis) really needs to sit with.
Why is thrombosis research so far behind when it comes to AI and multi-omics?
Our paper focuses on:
- Multi-omics (genomics, proteomics, metabolomics, etc.) is already transforming cancer and cardiovascular research.
- AI helps researchers make sense of massive, complex datasets that would otherwise be difficult to analyze.
- But in thrombosis research? Only FOUR studies have ever used AI with multi-omics.
That gap represents a problem, but also a great opportunity!
Blood clots kill.
Deep vein thrombosis, pulmonary embolism, and stroke are not rare events, particularly not in adults, and hospitalized children.
We have the tools to better predict, diagnose, and treat blood clots.
We are simply not (yet) using them broadly in this field.
In this paper, we are calling on the thrombosis community to step up.
Specifically, more collaboration, more training, more data sharing, and more investment in the next generation of researchers who can bridge the gap between biology and data science.
I am genuinely passionate about this space.”
Title: Artificial Intelligence (AI)-Empowered, Clinically-Integrated Multi-Omics Research in Thrombosis: A Call to Action
Authors: Steven Bruzek, Grant Vestal, Neil Goldenberg, Vera Ignjatovic
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy